Universal Biosensors : Launch of a New OneTouch Verio Meter

Universal Biosensors Inc

ARBN 121 559 993

1 Corporate Avenue

Rowville VIC 3178

Australia

Telephone [phone]

Facsimile [phone]

Email [e-mail] www.universalbiosensors.com
23 January 2015

Launch of a New OneTouch Verio® Meter

Universal Biosensors, Inc. (ASX: UBI) notes the release of a new OneTouch Verio® Meter by LifeScan. The new blood glucose monitoring meter has a color-coded range indicator that provides immediate feedback on whether a glucose reading is in or out of range.
For more information refer to the following links:
http://www.prnewswire.com/news-releases/new-onetouch-verio-blood-glucose-monitoring-system-helps-people-with-diabetes-better-understand-their-blood-sugar-test-results-with-no-extra-work-300022961.html
http://www.onetouch.com/verioMeter

Ends

Enquiries:
Mr Paul Wright: 03 9213 9000

About Universal Biosensors

For additional information in relation to Universal Biosensors, refer to http://www.universalbiosensors.com.
Universal Biosensors is a specialist medical diagnostics company, founded in 2001, that is focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use. These tests capitalise on a technology platform which uses a novel electrochemical cell that can be adapted for multiple analytes and provide for enhanced measurements in whole blood.

Universal Biosensors Inc

ARBN 121 559 993

1 Corporate Avenue

Rowville VIC 3178

Australia

Telephone [phone]

Facsimile [phone]

Email [e-mail] www.universalbiosensors.com

Forward-Looking Statements

The statements contained in this release that are not purely historical are forward-looking statements within the meaning of the Exchange Act. Forward-looking statements in this release include statements regarding our expectations, beliefs, hopes, intentions or strategies regarding the proposed offering. All forward-looking statements included in this release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. Our actual results could differ materially from our current expectations. We cannot assure you when, if at all, the proposed offering will occur, and the terms of any such offering are subject to change. Factors that could cause or contribute to such differences include, but are not limited to, factors and risks disclosed from time to time in reports filed with the SEC.